Kamada jumps on $50m source plasma deal...

Economics and markets | Jul 20, 2026, 12:42 PM

Kamada has signed a three-year agreement to supply normal source plasma from its collection centers in Texas.

The deal is expected to generate approximately $50 million in revenue over the three-year period.

PRO: see who's reacting and what you're missing. See the whole picture →